This post has been archived and contains information that may be out of date.
On May 28, the Centers for Medicare & Medicaid Services (CMS) issued new instructions for providers billing Chimeric Antigen Receptor (CAR) T-Cell therapy services for Medicare patients.
This content is restricted to members.
